These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Diosmin, a bioflavonoid reverses alterations in blood pressure, nitric oxide, lipid peroxides and antioxidant status in DOCA-salt induced hypertensive rats. Silambarasan T; Raja B Eur J Pharmacol; 2012 Mar; 679(1-3):81-9. PubMed ID: 22266490 [TBL] [Abstract][Full Text] [Related]
4. Digoxin amplifies the effects of deoxycorticosterone acetate (DOCA) in intact water-drinking rats: implications for the mechanism of DOCA hypertension? Li M; Martin A; Liu DT; Whitworth JA J Hypertens; 1994 May; 12(5):569-76. PubMed ID: 7930557 [TBL] [Abstract][Full Text] [Related]
5. Ouabain as an amplifier of mineralocorticoid-induced hypertension. Sekihara H; Yazaki Y; Kojima T Endocrinology; 1992 Dec; 131(6):3077-82. PubMed ID: 1446641 [TBL] [Abstract][Full Text] [Related]
6. Effect of diazoxide on serum and tissue electrolyte levels in rats with deoxycorticosterone acetate-induced hypertension. Nakai T J Pharm Sci; 1994 May; 83(5):704-7. PubMed ID: 8071825 [TBL] [Abstract][Full Text] [Related]
7. Lithium prevents saline deoxycorticosterone acetate (DOCA) hypertension in the rat. Iaina A; Shochat J; Serban I; Kapuler S; Gavendo S; Goldfarb D; Eliahou HE J Lab Clin Med; 1982 Feb; 99(2):231-8. PubMed ID: 6278037 [TBL] [Abstract][Full Text] [Related]
8. Antihypertensive effect of riboflavin analogs in rats with mineralocorticoid-induced hypertension. Trachewsky D Hypertension; 1981; 3(1):75-80. PubMed ID: 7203608 [TBL] [Abstract][Full Text] [Related]
9. Overflow of endogenous norepinephrine from PVH nucleus of DOCA-salt hypertensive rats. Qualy JM; Westfall TC Am J Physiol; 1995 Apr; 268(4 Pt 2):H1549-54. PubMed ID: 7733356 [TBL] [Abstract][Full Text] [Related]
10. Changes in renal and central noradrenergic activity with potassium in DOCA-salt rats. Fujita T; Sato Y Am J Physiol; 1984 May; 246(5 Pt 2):F670-5. PubMed ID: 6144278 [TBL] [Abstract][Full Text] [Related]
11. Spironolactone inhibits the activity of the Na+/H+ exchanger in the aorta of mineralocorticoid-induced hypertensive rats. CarreƱo JE; Verdugo FJ; Contreras F; Montellano FA; Veloso S; Schalper KA; Sandoval M; Villanueva S; Marusic E; Irarrazabal CE J Renin Angiotensin Aldosterone Syst; 2015 Dec; 16(4):1225-31. PubMed ID: 25997821 [TBL] [Abstract][Full Text] [Related]
12. Central effects of mineralocorticoid antagonist RU-28318 on blood pressure of DOCA-salt hypertensive rats. Van den Berg DT; de Kloet ER; de Jong W Am J Physiol; 1994 Dec; 267(6 Pt 1):E927-33. PubMed ID: 7810636 [TBL] [Abstract][Full Text] [Related]
13. Effect of parathyroidectomy on Sodium metabolism in DOCA-NaCl treated and spontaneously hypertensive rats. Pernot F; Berthelot A; Schleiffer R; Gairard A Arch Int Pharmacodyn Ther; 1983 Jul; 264(1):110-7. PubMed ID: 6625761 [TBL] [Abstract][Full Text] [Related]
14. Chronic blockade of endogenous atrial natriuretic polypeptide (ANP) by monoclonal antibody against ANP accelerates the development of hypertension in spontaneously hypertensive and deoxycorticosterone acetate-salt-hypertensive rats. Itoh H; Nakao K; Mukoyama M; Yamada T; Hosoda K; Shirakami G; Morii N; Sugawara A; Saito Y; Shiono S J Clin Invest; 1989 Jul; 84(1):145-54. PubMed ID: 2544622 [TBL] [Abstract][Full Text] [Related]
15. Experimental hypertension and other responses to 18-hydroxy-deoxycorticosterone treatment in the rat. Hall CE; Gomez-Sanchez CE; Holland OB; Nasseth D; Hall O Endocrinology; 1978 Jul; 103(1):133-40. PubMed ID: 744064 [TBL] [Abstract][Full Text] [Related]
16. Dietary chloride does not correlate with urinary thromboxane in deoxycorticosterone acetate-treated rats. Theriot JA; Passmore JC; Jimenez AE; Fleming JT J Lab Clin Med; 2000 Jun; 135(6):493-7. PubMed ID: 10850649 [TBL] [Abstract][Full Text] [Related]
17. Blood pressure versus direct mineralocorticoid effects on kidney inflammation and fibrosis in DOCA-salt hypertension. Klanke B; Cordasic N; Hartner A; Schmieder RE; Veelken R; Hilgers KF Nephrol Dial Transplant; 2008 Nov; 23(11):3456-63. PubMed ID: 18515791 [TBL] [Abstract][Full Text] [Related]
18. Emblica officinalis exerts antihypertensive effect in a rat model of DOCA-salt-induced hypertension: role of (p) eNOS, NO and oxidative stress. Bhatia J; Tabassum F; Sharma AK; Bharti S; Golechha M; Joshi S; Sayeed Akhatar M; Srivastava AK; Arya DS Cardiovasc Toxicol; 2011 Sep; 11(3):272-9. PubMed ID: 21748534 [TBL] [Abstract][Full Text] [Related]
19. Effect of manidipine on cardiac hypertrophy and coronary circulation in DOCA/salt hypertensive rats. Takeda K; Nakata T; Kuwabara T; Itoh H; Yamahara Y; Takesako T; Tanabe S; Sasaki S; Asayama J; Nakagawa M Blood Press Suppl; 1992; 3():48-52. PubMed ID: 1343289 [TBL] [Abstract][Full Text] [Related]
20. Changes in blood pressure and extracellular fluid with taurine in DOCA-salt rats. Fujita T; Sato Y Am J Physiol; 1986 Jun; 250(6 Pt 2):R1014-20. PubMed ID: 3717374 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]